Rafferty Asset Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $358K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $1.16M | Sell |
|
|||||
|
2022
Q4 | $2.34M | Buy |
|
|||||
|
2022
Q3 | $2.15M | Buy |
|
|||||
|
2022
Q2 | $1.28M | Sell |
|
|||||
|
2022
Q1 | $2.86M | Buy |
|
|||||
|
2021
Q4 | $2.82M | Buy |
|
|||||
|
2021
Q3 | $1.79M | Sell |
|
|||||
|
2021
Q2 | $2.5M | Sell |
|
|||||
|
2021
Q1 | $3.62M | Buy |
|
|||||
|
2020
Q4 | $934K | Sell |
|
|||||
|
2020
Q3 | $1.78M | Buy |
|
|||||
|
2020
Q2 | $643K | Buy |
|
|||||
|
2020
Q1 | $98K | Sell |
|
|||||
|
2019
Q4 | $1.09M | Sell |
|
|||||
|
2019
Q3 | $2.45M | Buy |
|
|||||
|
2019
Q2 | $2.83M | Sell |
|
|||||
|
2019
Q1 | $2.72M | Buy |
|